Beijing Succeeder Technology Inc.

SHSE:688338 Stock Report

Market Cap: CN¥2.7b

Beijing Succeeder Technology Past Earnings Performance

Past criteria checks 1/6

Beijing Succeeder Technology has been growing earnings at an average annual rate of 14.2%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 6.1% per year. Beijing Succeeder Technology's return on equity is 6.9%, and it has net margins of 37.9%.

Key information

14.2%

Earnings growth rate

8.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate6.1%
Return on equity6.9%
Net Margin37.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think That There Are Some Issues For Beijing Succeeder Technology (SHSE:688338) Beyond Its Promising Earnings

Nov 06
We Think That There Are Some Issues For Beijing Succeeder Technology (SHSE:688338) Beyond Its Promising Earnings

Beijing Succeeder Technology (SHSE:688338) Strong Profits May Be Masking Some Underlying Issues

May 01
Beijing Succeeder Technology (SHSE:688338) Strong Profits May Be Masking Some Underlying Issues

Recent updates

We Think That There Are Some Issues For Beijing Succeeder Technology (SHSE:688338) Beyond Its Promising Earnings

Nov 06
We Think That There Are Some Issues For Beijing Succeeder Technology (SHSE:688338) Beyond Its Promising Earnings

Investors Still Aren't Entirely Convinced By Beijing Succeeder Technology Inc.'s (SHSE:688338) Earnings Despite 36% Price Jump

Oct 09
Investors Still Aren't Entirely Convinced By Beijing Succeeder Technology Inc.'s (SHSE:688338) Earnings Despite 36% Price Jump

Beijing Succeeder Technology (SHSE:688338) Strong Profits May Be Masking Some Underlying Issues

May 01
Beijing Succeeder Technology (SHSE:688338) Strong Profits May Be Masking Some Underlying Issues

Revenue & Expenses Breakdown

How Beijing Succeeder Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688338 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242981136021
31 Mar 242851215520
31 Dec 232751175119
30 Sep 232691144918
30 Jun 232641174917
31 Mar 232461124417
31 Dec 222291044317
30 Sep 222401094415
30 Jun 222351034614
31 Mar 22238964714
31 Dec 21240974815
30 Sep 21235964614
30 Jun 21234864514
31 Mar 21241854314
31 Dec 20222694213
30 Sep 20222634414
30 Jun 20220664314
31 Mar 20207594513
31 Dec 19230714513
31 Dec 18200574012
31 Dec 17157294212

Quality Earnings: 688338 has a high level of non-cash earnings.

Growing Profit Margin: 688338's current net profit margins (37.9%) are lower than last year (42.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688338's earnings have grown by 14.2% per year over the past 5 years.

Accelerating Growth: 688338's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688338 had negative earnings growth (-0.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688338's Return on Equity (6.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:06
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Succeeder Technology Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Feifei XuChina Merchants Securities Co. Ltd.
Mingrui WangEverbright Securities Co. Ltd.
Yijiang LiEverbright Securities Co. Ltd.